BMY vs JNJ
BMY and JNJ side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BMYBRISTOL-MYERS SQUIBB COMPANY | JNJJohnson & Johnson |
|---|---|---|
| Market cap | $136.00B | $645.90B |
| P/E (TTM) | 14.7 | 31.1 |
| P/B | 6.09 | 7.60 |
| P/S | 2.8x | 6.9x |
| Dividend yield | 3.71% | 1.92% |
| Revenue | $49.19B(TTM) | $97.93B(TTM) |
| Revenue growth (YoY) | -0.2% | 6.0% |
| Net income | $9.28B(TTM) | $21.04B(TTM) |
| Earnings growth (YoY) | 178.8% | 90.6% |
| EPS, diluted | $4.54(TTM) | $8.62(TTM) |
| EBIT margin | 21.8% | 22.9% |
| ROE | 31.6% | 31.5% |
| ROIC | 14.0% | 16.1% |
| Piotroski F | 7/9 | 6/9 |
| 1y total return | +47.3% | +55.7% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BMY vs JNJ
| Metric | BMY | JNJ |
|---|---|---|
| End value | $13.6K | $31.6K |
| Total return | +35.6% | +216.3% |
| CAGR | +3.0% | +11.8% |
| Volatility | 25.3% | 18.6% |
| Sharpe | 0.09 | 0.48 |
| Sortino | 0.12 | 0.69 |
| Max drawdown | -47.7% | -27.4% |
Based on 2600 common trading days, 2016-04-27 → 2026-08-28 · risk-free 3.9% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)